血行動態モニタリングシステムの市場規模、シェア、成長分析：タイプ別、製品別、モダリティ別、地域別 - 産業予測 2025～2032年

血行動態モニタリングシステム市場規模は、2023年に11億6,000万米ドルと評価され、2024年の12億3,000万米ドルから2032年には20億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.4％で成長する見通しです。

血行動態モニタリングシステム市場は、主に技術革新と低血圧予測指数（HPI）ソフトウェアの登場によって力強い成長を遂げています。継続的な調査と心血管疾患や糖尿病の有病率の上昇が、高度なモニタリングソリューションへの需要を高めています。さらに、高齢者人口の増加や外科手術の頻度の増加が市場促進要因となっています。また、業界各社はこれらのシステムの利点について認識を高めつつあり、市場浸透をさらに後押ししています。さらに、微小電気機械システム（MEMS）の採用は、患者ケアにおける先進技術への取り組みを反映しています。ヘルスケアインフラの強化を目指す政府のイニシアティブは、市場の拡大を支える極めて重要なものであり、クリティカルケア環境での継続的な注目を確実なものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ

血行動態モニタリングシステム市場規模：タイプ別& CAGR（2025-2032）

• 侵襲的
• 低侵襲
• 非侵襲的

血行動態モニタリングシステム市場規模：製品別& CAGR（2025-2032）

• モニター
  • 心拍出量モニタリングシステム
  • 肺動脈カテーテル（PACS）
• 使い捨て
  • プローブ
  • エアフローセンサー

血行動態モニタリングシステム市場規模：モダリティ別& CAGR（2025-2032）

• 床/壁掛け
• 据え置き型
• ポータブル

血行動態モニタリングシステム市場規模：エンドユーザー別& CAGR（2025-2032）

• 病院
• 診療所および外来診療センター
• 在宅ケアの設定

血行動態モニタリングシステム市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Edwards Lifesciences Corporation
• GE Healthcare（General Electric Company）
• ICU Medical
• Koninklijke Philips N.V.（Philips）
• NI Medical
• Nihon Kohen
• Medtronic Plc.
• Abbott Laboratories
• Getinge AB
• Deltex Medical Group
• Masimo
• Osypka Medical GmbH
• Schwarzer Cardiotek GmbH
• Shanshi Medical Group
• Bistos Co.Ltd.
• Uscom
• Caretaker Medical
• Cnsystems Medizintechnik GmbH

結論と推奨事項

Hemodynamic Monitoring Systems Market size was valued at USD 1.16 Billion in 2023 and is poised to grow from USD 1.23 Billion in 2024 to USD 2.04 Billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The hemodynamic monitoring systems market is experiencing robust growth, primarily fueled by technological innovations and the advent of hypotension prediction index (HPI) software, which enhance device precision and capabilities. Ongoing research and the rising prevalence of cardiovascular diseases and diabetes have amplified the demand for sophisticated monitoring solutions. Additionally, an increasing geriatric population and more frequent surgical interventions are critical market drivers. Industry players are also building awareness about the advantages of these systems, further boosting market penetration. Furthermore, the adoption of microelectromechanical systems (MEMS) reflects a commitment to advanced technologies in patient care. Government-backed initiatives aimed at strengthening healthcare infrastructure are pivotal in supporting market expansion, ensuring continued prominence in critical care environments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hemodynamic Monitoring Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hemodynamic Monitoring Systems Market Segments Analysis

Global Hemodynamic Monitoring Systems Market is segmented by Type, by Product, by Modality, by End User and by Region. Based on Type, the market is segmented into Invasive, Minimally invasive, Non-invasive. Based on Product, the market is segmented into Monitors, Disposables. Based on Modality, the market is segmented into Floor/wall mounted, Benchtop, Portable. Based on End User, the market is segmented into Hospitals, Clinics and ambulatory care centers, home care settings. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Hemodynamic Monitoring Systems Market

The hemodynamic monitoring systems market is significantly driven by ongoing technological innovations that have led to the development of advanced, precise, and non-invasive monitoring devices. These breakthroughs are transforming patient care by improving health outcomes and enhancing the efficiency of healthcare services. The introduction of non-invasive hemodynamic monitoring solutions, which rely on sensors applied to the skin to assess blood flow and pressure, has meticulously changed the landscape of monitoring practices. This transition not only augments the accuracy of measurements but also elevates the comfort for patients, thereby playing a crucial role in shaping the future of hemodynamic monitoring.

Restraints in the Hemodynamic Monitoring Systems Market

The Hemodynamic Monitoring Systems market faces several restraints, particularly due to the growing popularity of noninvasive hemodynamic monitoring systems. These advanced systems provide significant benefits in medical diagnostics by allowing painless assessments while reducing the potential for blood-borne infections. Their user-friendly design makes them suitable for use by nursing staff without the need for specialized training, streamlining the process of monitoring multiple patients simultaneously. This efficiency ultimately leads to lower staffing requirements and decreased treatment costs. As a result, noninvasive systems are increasingly viewed as essential tools in modern healthcare, potentially hindering the growth of conventional invasive hemodynamic monitoring systems.

Market Trends of the Hemodynamic Monitoring Systems Market

The hemodynamic monitoring systems market is experiencing significant growth, driven by the rising population of critically ill elderly patients, a surge in chronic conditions such as heart diseases and diabetes, and an increasing demand for home-based, non-invasive monitoring solutions. As the global demographic shifts towards an aging population, the need for advanced monitoring systems has intensively escalated to address the complexities of critical illnesses. Furthermore, the alarming prevalence of hypertension fosters an environment ripe for innovation and investment in hemodynamic technologies. This amalgamation of factors positions the market for robust expansion, catering to both healthcare facilities and the evolving homecare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Hemodynamic Monitoring Systems Market Size by Type & CAGR (2025-2032)

• Invasive
• Minimally invasive
• Noninvasive

Global Hemodynamic Monitoring Systems Market Size by Product & CAGR (2025-2032)

• Monitors
  • Cardiac output monitoring systems
  • Pulmonary artery catheters (pacs)
• Disposables
  • Probes
  • Air Flow Sensors

Global Hemodynamic Monitoring Systems Market Size by Modality & CAGR (2025-2032)

• Floor/wall mounted
• Benchtop
• Portable

Global Hemodynamic Monitoring Systems Market Size by End User & CAGR (2025-2032)

• Hospitals
• Clinics and ambulatory care centers
• Home care settings

Global Hemodynamic Monitoring Systems Market Size by Region & CAGR (2025-2032)

• North America, (by Type, by Product, by Modality, by End User)
  • US
  • Canada
• Europe, (by Type, by Product, by Modality, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Type, by Product, by Modality, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Type, by Product, by Modality, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Type, by Product, by Modality, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (General Electric Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Philips)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NI Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deltex Medical Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka Medical GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schwarzer Cardiotek GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanshi Medical Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bistos Co.Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uscom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caretaker Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cnsystems Medizintechnik GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation